Hudson Bay Capital Management LP - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is INM and the CUSIP is 457637502. A total of 22 filers reported holding INMED PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$531,000161,0000.01%
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Empery Asset Management, LP 61,741$58,0000.27%
AllSquare Wealth Management LLC 545$1,0000.00%
TWO SIGMA SECURITIES, LLC 17,979$17,0000.00%
Creative Planning 10,832$10,0000.00%
Federation des caisses Desjardins du Quebec 511$4820.00%
TCI Wealth Advisors, Inc. 125$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HC FINANCIAL ADVISORS INC 24$00.00%
OSAIC HOLDINGS, INC. 1,185$1,0000.00%
GABLES CAPITAL MANAGEMENT INC. 30$00.00%
View complete list of INMED PHARMACEUTICALS INC shareholders